Vexol is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc. The primary component is Rimexolone.
| Product ID | 0065-0627_047301fe-73f6-356c-ec16-a1123037f239 |
| NDC | 0065-0627 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vexol |
| Generic Name | Rimexolone |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1995-09-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020474 |
| Labeler Name | Alcon Laboratories, Inc |
| Substance Name | RIMEXOLONE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1995-09-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020474 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1995-09-15 |
| Marketing End Date | 2017-02-20 |
| Marketing Category | NDA |
| Application Number | NDA020474 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1995-09-15 |
| Marketing End Date | 2011-07-28 |
| Marketing Category | NDA |
| Application Number | NDA020474 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1995-09-15 |
| Marketing End Date | 2011-07-28 |
| Marketing Category | NDA |
| Application Number | NDA020474 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1995-09-15 |
| Marketing End Date | 2016-03-10 |
| Ingredient | Strength |
|---|---|
| RIMEXOLONE | 10 mg/mL |
| SPL SET ID: | b1699f4e-40d5-49d0-ab80-1c8cc68e80a4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VEXOL 74479305 1960827 Live/Registered |
Alcon Laboratories, Inc. 1994-01-13 |